Diazepam kinetics in acute alcohol withdrawal. 1979

S M Pond, and M Phillips, and N L Benowitz, and R E Galinsky, and T G Tong, and C E Becker

We performed a within-subject comparison of the kinetics of diazepam given to 7 alcoholic subjects during acute alcohol withdrawal and again after detoxification. The initial rapid exponential decline of plasma diazepam concentrations (t1/2 alpha) was more rapid during (0.21 +/- 0.03 hr) than after withdrawal (0.44 +/- 0.14 hr, p less than 0.05). Terminal t1/2, clearance, and volumes of distribution changed in individual patients, but mean values did not change. Protein binding was less in patients (93.4 +/- 2.4%) than in healthy controls (97.0 +/- 1.0, p less than 0.05). The effects of alcohol withdrawal on diazepam disposition do not explain the high doses of diazepam commonly required to treat the withdrawal.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000437 Alcoholism A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4) Alcohol Abuse,Alcoholic Intoxication, Chronic,Ethanol Abuse,Alcohol Addiction,Alcohol Dependence,Alcohol Use Disorder,Abuse, Alcohol,Abuse, Ethanol,Addiction, Alcohol,Alcohol Use Disorders,Chronic Alcoholic Intoxication,Dependence, Alcohol,Intoxication, Chronic Alcoholic,Use Disorders, Alcohol

Related Publications

S M Pond, and M Phillips, and N L Benowitz, and R E Galinsky, and T G Tong, and C E Becker
October 1977, Science (New York, N.Y.),
S M Pond, and M Phillips, and N L Benowitz, and R E Galinsky, and T G Tong, and C E Becker
May 1990, International journal of clinical pharmacology, therapy, and toxicology,
S M Pond, and M Phillips, and N L Benowitz, and R E Galinsky, and T G Tong, and C E Becker
December 1983, Clinical pharmacology and therapeutics,
S M Pond, and M Phillips, and N L Benowitz, and R E Galinsky, and T G Tong, and C E Becker
January 1983, British journal of clinical pharmacology,
S M Pond, and M Phillips, and N L Benowitz, and R E Galinsky, and T G Tong, and C E Becker
January 1984, Journal of toxicology. Clinical toxicology,
S M Pond, and M Phillips, and N L Benowitz, and R E Galinsky, and T G Tong, and C E Becker
October 1995, Psychopharmacology,
S M Pond, and M Phillips, and N L Benowitz, and R E Galinsky, and T G Tong, and C E Becker
June 2007, The American journal of medicine,
S M Pond, and M Phillips, and N L Benowitz, and R E Galinsky, and T G Tong, and C E Becker
August 1993, The Indian journal of medical research,
S M Pond, and M Phillips, and N L Benowitz, and R E Galinsky, and T G Tong, and C E Becker
December 1989, Biological psychiatry,
S M Pond, and M Phillips, and N L Benowitz, and R E Galinsky, and T G Tong, and C E Becker
November 1983, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!